Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

Moderna Inc (MRNA)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
103.16 +0.07    +0.07%
13:36:15 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,676,631
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 99.33 - 104.82
Moderna 103.16 +0.07 +0.07%

Moderna Inc Company Profile

 
Get an in-depth profile of Moderna Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

3900

Equity Type

ORD

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 200 Technology Square
Cambridge, 02139
United States
Phone 617 714 6500
Fax -
Web www.modernatx.com

Top Executives

Name Age Since Title
Robert S. Langer 73 2010 Independent Non Executive Director & Member of Scientific Advisory Board
Jack W. Szostak - 2014 Chairman of Scientific Advisory Board
Elizabeth Edith Tallett 72 2020 Independent Director
Scott A. Canute 61 2014 Member of Technology Advisory Board
Ulrich H. von Andrian-Werburg - - Member of Scientific Advisory Board
Fred E. Regnier - 2014 Member of Technology Advisory Board
Richard C. Willson - 2014 Member of Technology Advisory Board
John G. Aunins 61 2014 Member of Technology Advisory Board
James R. Swartz - 2014 Member of Technology Advisory Board
Sandra J. Horning 73 2020 Independent Director
Elizabeth G. Nabel 70 2021 Independent Director
Noubar B. Afeyan 60 2010 Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
Stephane Bancel 50 2011 CEO & Director
Ron Eydelloth - - Member of Scientific Advisory Board
Rachel Green - - Member of Scientific Advisory Board
Paul L. Sagan 64 2018 Independent Non Executive Director
Ralph Weissleder - - Member of Scientific Advisory Board
Paula T. Hammond 59 - Member of Scientific Advisory Board
Michael Diamond - - Member of Scientific Advisory Board
Stephen A. Berenson 62 2017 Independent Non Executive Director
Francois Nader 66 2019 Independent Non Executive Director
Melissa J. Moore - 2016 Chief Scientific Officer & Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Flavio Man
Flavio Man Sep 28, 2023 8:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Afeyan selling again. Down we go.
Reply
2 1
Report
Flavio Man
Flavio Man Sep 25, 2023 10:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$75 next stop before final target at $10. Stay short
Reply
2 2
Report
Flavio Man
Flavio Man Sep 21, 2023 8:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Afeyan again dumping the stock. Short in comfort.
Reply
4 2
Report
Mr George
Mr George Sep 21, 2023 8:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Nice Flavio, so far it seems it's returning to the bearish way. I wouldn't short it because there is too much covid pulling up again right? So to me it's dangerous
Reply
0 0
Report
Flavio Man
Flavio Man Sep 21, 2023 8:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Mr George Fair enough George. Peace.
Reply
0 0
Report
Mr George
Mr George Sep 21, 2023 8:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
don't you think that it can reverse aggressively to the upside because if the covid cases increasing?
Reply
0 0
Report
Flavio Man
Flavio Man Sep 20, 2023 9:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Stay short.
Reply
3 1
Report
Atlantic Coast Money
Atlantic Coast Money Sep 18, 2023 12:24PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
When this heads to the pink sheets and trades over the counter the ticker will be FAUCI
Reply
3 2
Report
Flavio Man
Flavio Man Sep 18, 2023 11:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hey herb (aka mr geoge), im thinking of you.
Reply
3 3
Report
Flavio Man
Flavio Man Sep 18, 2023 9:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
More executives selling.
Reply
6 4
Report
Flavio Man
Flavio Man Sep 15, 2023 7:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Afeyan keeps dumping shares.
Reply
4 3
Report
Mr George
Mr George Sep 14, 2023 10:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Another 3.89% lost today Flavio? lol. Sell sell!
Reply
0 5
Report
Flavio Man
Flavio Man Sep 14, 2023 10:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lol
Reply
3 0
Report
Flavio Man
Flavio Man Sep 13, 2023 3:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You herb mr geoge
Reply
3 2
Report
Mr George
Mr George Sep 13, 2023 3:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Did you sell at 95 and these days peaks too? You seemed pretty convinced but now losing big money and maybe you made others lose it too...
Reply
0 3
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email